Learn More
PURPOSE We study toxicity and efficacy of sequential intravesical therapy with mitomycin C and bacillus Calmette-Guerin (BCG) in patients with intermediate or high risk superficial bladder cancer(More)
PURPOSE Despite current treatment after transurethral resection of a bladder tumor, recurrences and progression remain a problem. Keyhole limpet hemocyanin (KLH) was beneficial in earlier studies. In(More)
The treatment of hormone resistant prostate cancer) with epirubicin 25 mg/m2 (Epi25) on a weekly intravenous regimen may be better in terms of health related quality of life (HRQOL) than with 100(More)
PURPOSE We quantified the physiological variability of clinical and pressure-flow study variables in patients with symptomatic benign prostatic enlargement. MATERIALS AND METHODS Symptom scores(More)